4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-019501
Director sold 7,500 shares at $62.00 ($465,000)
- Director acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J Director | 2018-07-03 | Option exercise | +5,816 | $5.59 | $32,511 | 5,816 | D |
| CAGNONI PABLO J Director | 2018-07-03 | Sale | −5,816 | $62.00 | $360,592 | 0 | D |
| CAGNONI PABLO J Director | 2018-07-05 | Option exercise | +1,684 | $5.59 | $9,414 | 1,684 | D |
| CAGNONI PABLO J Director | 2018-07-05 | Sale | −1,684 | $62.00 | $104,408 | 0 | D |
| Derivatives | |||||||
| CAGNONI PABLO J Director | 2018-07-03 | Option exercise · Stock Option (Right to Buy) | +5,816 | 88,017 | D | ||
| CAGNONI PABLO J Director | 2018-07-05 | Option exercise · Stock Option (Right to Buy) | +1,684 | 86,333 | D | ||
| Open-market sales · 7,500 sh · avg $62.00 · $465,000 | |||||||
Loading xslF345X03/doc4.xml…